Figshareopen access
Supporting data for "Pt1a and tyrosine kinase inhibitor combination treatment exerts synergistic anti-hepatocellular carcinoma effect through RNA m6A methylation modification".
cancer cell biology, sorafenib combination therapy, hepatocellular carcinoma, pt1a
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 344096
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.